nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Vision blurred—Mitomycin—urinary bladder cancer	0.00578	0.00578	CcSEcCtD
Prilocaine—Pain—Carboplatin—urinary bladder cancer	0.00575	0.00575	CcSEcCtD
Prilocaine—Anaemia—Mitomycin—urinary bladder cancer	0.00567	0.00567	CcSEcCtD
Prilocaine—Neuropathy—Gemcitabine—urinary bladder cancer	0.00557	0.00557	CcSEcCtD
Prilocaine—Syncope—Mitomycin—urinary bladder cancer	0.0055	0.0055	CcSEcCtD
Prilocaine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00539	0.00539	CcSEcCtD
Prilocaine—Hypertension—Mitomycin—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Prilocaine—Cardiac failure—Thiotepa—urinary bladder cancer	0.00525	0.00525	CcSEcCtD
Prilocaine—Asthenia—Valrubicin—urinary bladder cancer	0.00521	0.00521	CcSEcCtD
Prilocaine—Neuropathy—Cisplatin—urinary bladder cancer	0.00519	0.00519	CcSEcCtD
Prilocaine—Confusional state—Mitomycin—urinary bladder cancer	0.00505	0.00505	CcSEcCtD
Prilocaine—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00501	0.00501	CcSEcCtD
Prilocaine—Oedema—Mitomycin—urinary bladder cancer	0.005	0.005	CcSEcCtD
Prilocaine—Shock—Mitomycin—urinary bladder cancer	0.00492	0.00492	CcSEcCtD
Prilocaine—Cardiac arrest—Thiotepa—urinary bladder cancer	0.00487	0.00487	CcSEcCtD
Prilocaine—Dizziness—Valrubicin—urinary bladder cancer	0.0048	0.0048	CcSEcCtD
Prilocaine—Swelling—Fluorouracil—urinary bladder cancer	0.0048	0.0048	CcSEcCtD
Prilocaine—Hypoxia—Methotrexate—urinary bladder cancer	0.00478	0.00478	CcSEcCtD
Prilocaine—Neuropathy—Etoposide—urinary bladder cancer	0.00476	0.00476	CcSEcCtD
Prilocaine—Disorientation—Fluorouracil—urinary bladder cancer	0.00473	0.00473	CcSEcCtD
Prilocaine—Vomiting—Valrubicin—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.00445	0.00445	CcSEcCtD
Prilocaine—Somnolence—Mitomycin—urinary bladder cancer	0.00445	0.00445	CcSEcCtD
Prilocaine—Cardiac failure—Gemcitabine—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Prilocaine—Paralysis—Methotrexate—urinary bladder cancer	0.00437	0.00437	CcSEcCtD
Prilocaine—Cardiac failure—Fluorouracil—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Prilocaine—Nausea—Valrubicin—urinary bladder cancer	0.00432	0.00432	CcSEcCtD
Prilocaine—Cyanosis—Methotrexate—urinary bladder cancer	0.00429	0.00429	CcSEcCtD
Prilocaine—Pain—Mitomycin—urinary bladder cancer	0.00428	0.00428	CcSEcCtD
Prilocaine—Osteoarthritis—Fluorouracil—urinary bladder cancer	0.00424	0.00424	CcSEcCtD
Prilocaine—Swelling—Etoposide—urinary bladder cancer	0.00417	0.00417	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00415	0.00415	CcSEcCtD
Prilocaine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00412	0.00412	CcSEcCtD
Prilocaine—Paralysis—Epirubicin—urinary bladder cancer	0.00409	0.00409	CcSEcCtD
Prilocaine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00403	0.00403	CcSEcCtD
Prilocaine—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Prilocaine—Paralysis—Doxorubicin—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Prilocaine—Cardiac failure—Etoposide—urinary bladder cancer	0.00377	0.00377	CcSEcCtD
Prilocaine—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00366	0.00366	CcSEcCtD
Prilocaine—Feeling hot—Epirubicin—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Prilocaine—Asthenia—Mitomycin—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Prilocaine—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00355	0.00355	CcSEcCtD
Prilocaine—Cardiac arrest—Etoposide—urinary bladder cancer	0.0035	0.0035	CcSEcCtD
Prilocaine—Extravasation—Methotrexate—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Prilocaine—Feeling hot—Doxorubicin—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Prilocaine—Dizziness—Mitomycin—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Prilocaine—Tinnitus—Thiotepa—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Prilocaine—Extravasation—Epirubicin—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Prilocaine—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Prilocaine—Dysarthria—Methotrexate—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Prilocaine—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Prilocaine—Sweating—Gemcitabine—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Prilocaine—Vomiting—Mitomycin—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Prilocaine—Arrhythmia—Thiotepa—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Prilocaine—Bronchospasm—Etoposide—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Prilocaine—Respiratory failure—Methotrexate—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Prilocaine—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Prilocaine—Tension—Thiotepa—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Prilocaine—Extravasation—Doxorubicin—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Prilocaine—Dysarthria—Epirubicin—urinary bladder cancer	0.003	0.003	CcSEcCtD
Prilocaine—Nervousness—Thiotepa—urinary bladder cancer	0.003	0.003	CcSEcCtD
Prilocaine—Nausea—Mitomycin—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Prilocaine—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Prilocaine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00292	0.00292	CcSEcCtD
Prilocaine—Vision blurred—Thiotepa—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Prilocaine—Anaemia—Thiotepa—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Prilocaine—Bradycardia—Cisplatin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Prilocaine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Prilocaine—Neuropathy—Epirubicin—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Prilocaine—Hypertension—Thiotepa—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Prilocaine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Prilocaine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Prilocaine—Anxiety—Thiotepa—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Prilocaine—Tinnitus—Cisplatin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Prilocaine—Confusional state—Thiotepa—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Prilocaine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Prilocaine—Arrhythmia—Cisplatin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Prilocaine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Prilocaine—Vision blurred—Fluorouracil—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Prilocaine—Anaemia—Gemcitabine—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Prilocaine—Anaemia—Fluorouracil—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Prilocaine—Vision blurred—Cisplatin—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Prilocaine—Tremor—Cisplatin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Prilocaine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Prilocaine—Hypertension—Gemcitabine—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Prilocaine—Somnolence—Thiotepa—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Prilocaine—Anaemia—Cisplatin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Prilocaine—Osteoarthritis—Methotrexate—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Prilocaine—Pain—Thiotepa—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Prilocaine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Prilocaine—Oedema—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Prilocaine—Cardiac failure—Epirubicin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Prilocaine—Confusional state—Fluorouracil—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Prilocaine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Prilocaine—Oedema—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Prilocaine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Prilocaine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Prilocaine—Diplopia—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Prilocaine—Osteoarthritis—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Prilocaine—Anxiety—Cisplatin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Prilocaine—Anaemia—Etoposide—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Prilocaine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Prilocaine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Prilocaine—Urticaria—Thiotepa—urinary bladder cancer	0.002	0.002	CcSEcCtD
Prilocaine—Hypotension—Gemcitabine—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Prilocaine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Prilocaine—Oedema—Cisplatin—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Prilocaine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Prilocaine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Prilocaine—Hypotension—Fluorouracil—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Prilocaine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Prilocaine—Hypertension—Etoposide—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Prilocaine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Prilocaine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Prilocaine—Somnolence—Gemcitabine—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Prilocaine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Prilocaine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Prilocaine—Somnolence—Fluorouracil—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Prilocaine—Hypotension—Cisplatin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Prilocaine—Confusional state—Etoposide—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Prilocaine—Pain—Gemcitabine—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Prilocaine—Asthenia—Thiotepa—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Prilocaine—Pain—Fluorouracil—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Prilocaine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Prilocaine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Prilocaine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Prilocaine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Prilocaine—Hypotension—Etoposide—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Prilocaine—Pain—Cisplatin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Prilocaine—Dizziness—Thiotepa—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Prilocaine—Urticaria—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Prilocaine—Sweating—Methotrexate—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Prilocaine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Prilocaine—Paraesthesia—Etoposide—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Prilocaine—Somnolence—Etoposide—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Prilocaine—Vomiting—Thiotepa—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Prilocaine—Pain—Etoposide—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Prilocaine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Prilocaine—Sweating—Epirubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Prilocaine—Asthenia—Gemcitabine—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Prilocaine—Nausea—Thiotepa—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Prilocaine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Prilocaine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Prilocaine—Bradycardia—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Prilocaine—Urticaria—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Prilocaine—Tinnitus—Methotrexate—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Prilocaine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Prilocaine—Asthenia—Cisplatin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Prilocaine—Sweating—Doxorubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Prilocaine—Dizziness—Fluorouracil—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Prilocaine—Vomiting—Gemcitabine—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Prilocaine—Vomiting—Fluorouracil—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Prilocaine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Prilocaine—Asthenia—Etoposide—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Prilocaine—Nausea—Gemcitabine—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Prilocaine—Vomiting—Cisplatin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Prilocaine—Nausea—Fluorouracil—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Prilocaine—Tinnitus—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Prilocaine—Tension—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Prilocaine—Nervousness—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Prilocaine—Dizziness—Etoposide—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Prilocaine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Prilocaine—Nausea—Cisplatin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Prilocaine—Vision blurred—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Prilocaine—Vomiting—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Prilocaine—Anaemia—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Prilocaine—Tension—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Prilocaine—Nervousness—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Prilocaine—Syncope—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Prilocaine—Confusional state—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Prilocaine—Nausea—Etoposide—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Prilocaine—Hypertension—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Prilocaine—Anxiety—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Prilocaine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Prilocaine—Syncope—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Prilocaine—Confusional state—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Prilocaine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Prilocaine—Oedema—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Prilocaine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Prilocaine—Shock—Epirubicin—urinary bladder cancer	0.000997	0.000997	CcSEcCtD
Prilocaine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000994	0.000994	CcSEcCtD
Prilocaine—Hypertension—Doxorubicin—urinary bladder cancer	0.000992	0.000992	CcSEcCtD
Prilocaine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00098	0.00098	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—urinary bladder cancer	0.000975	0.000975	CcSEcCtD
Prilocaine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000972	0.000972	CcSEcCtD
Prilocaine—Somnolence—Methotrexate—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Prilocaine—Hypotension—Epirubicin—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Prilocaine—Confusional state—Doxorubicin—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Prilocaine—Pain—Methotrexate—urinary bladder cancer	0.000926	0.000926	CcSEcCtD
Prilocaine—Shock—Doxorubicin—urinary bladder cancer	0.000923	0.000923	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Prilocaine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00091	0.00091	CcSEcCtD
Prilocaine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000906	0.000906	CcSEcCtD
Prilocaine—Somnolence—Epirubicin—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Prilocaine—Pain—Epirubicin—urinary bladder cancer	0.000867	0.000867	CcSEcCtD
Prilocaine—Urticaria—Methotrexate—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Prilocaine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000842	0.000842	CcSEcCtD
Prilocaine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000835	0.000835	CcSEcCtD
Prilocaine—Somnolence—Doxorubicin—urinary bladder cancer	0.000834	0.000834	CcSEcCtD
Prilocaine—Urticaria—Epirubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Prilocaine—Pain—Doxorubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Prilocaine—Asthenia—Methotrexate—urinary bladder cancer	0.000777	0.000777	CcSEcCtD
Prilocaine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Prilocaine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Prilocaine—Urticaria—Doxorubicin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Prilocaine—Asthenia—Epirubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Prilocaine—Dizziness—Methotrexate—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Prilocaine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000691	0.000691	CcSEcCtD
Prilocaine—Vomiting—Methotrexate—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Prilocaine—Asthenia—Doxorubicin—urinary bladder cancer	0.000673	0.000673	CcSEcCtD
Prilocaine—Dizziness—Epirubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Prilocaine—Vomiting—Epirubicin—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Prilocaine—Nausea—Methotrexate—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Prilocaine—Dizziness—Doxorubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Prilocaine—Nausea—Epirubicin—urinary bladder cancer	0.000602	0.000602	CcSEcCtD
Prilocaine—Vomiting—Doxorubicin—urinary bladder cancer	0.000596	0.000596	CcSEcCtD
Prilocaine—Nausea—Doxorubicin—urinary bladder cancer	0.000557	0.000557	CcSEcCtD
